Captopril Articles

Captopril Reduces Diabetes Mortality

15 November 1993

ACE INHIBITORS POST-MI: THE PRACTICAL STUDY

15 November 1993

ADA ISSUES HYPERTENSION IN DIABETES GUIDELINES

8 November 1993

US 3rd QTR AFFECTED BY STRONG DOLLAR

1 November 1993

HOECHST CELANESE ACQUIRES US GENERICS CO

25 October 1993

CAPTOPRIL APPROVED FOR POST-MI USE

11 October 1993

TOP PEOPLE MOVING IN US PHARMA FIRMS

27 September 1993

ZESTRIL APPROVED FOR GP INITIATION

6 September 1993

RESULTS OF AIRE STUDY SHOW ACE INHIB BENEFIT

6 September 1993

US DRUGSTORE AUDIT DATA FOR JULY

6 September 1993

UK INDUSTRY CODE OF PRACTICE REVIEW

19 July 1993

ZESTRIL APPROVED FOR CHF IN USA

21 June 1993

SANOFI ALLIANCE WITH BRISTOL-MYERS SQUIBB

7 June 1993

THREE-WAY GENERIC AGREEMENT

31 May 1993

SPANISH FIRM ESTEVE INTERNATIONALIZES

10 May 1993

ACE INHIBITOR STUDY

19 April 1993

PRICE FLEXIBILITY AND THE DRUG INDUSTRY

12 April 1993

FDA PANEL ADVISES ON ACE INHIBITOR DRUGS

1 March 1993

GENTA'S JAGOTEC IN JV WITH GENSIA

22 February 1993

FIRST LAUNCH OF ROUSSEL UCLAF'S TRANDOLAPRIL

25 January 1993

GLOBAL DRUG MARKET: 30 YEARS OF GROWTH

4 January 1993

SAVE STUDY CONFIRMS ACE INHIBITOR BENEFITS

7 September 1992

UPDATE ON ISIS-4 PROGRESS

6 July 1992

CAPOTEN CUTS MORTALITY IN SAVE

27 April 1992

NITRATES: OLD DRUGS, BUT ONES WITH A FUTURE

20 April 1992

STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB

20 April 1992

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

TEN YEARS OF ACE INHIBITION

23 March 1992

B-M SQUIBB GIVES HEART DRUGS FREE TO POOR

3 February 1992

B-M SQUIBB CUTS HEALTH PROGRAM DRUG PRICES

13 January 1992

EC PLENARY SESSION DECISIONS

6 January 1992

Showing 101-132 of 132 articles

Go to beginningPreviousNextGo to end